Efavirenz-containing regimen superior in advanced HIV

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1331, 2002-01, pp. : 13-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efavirenz-containing regimens superior in HIV-1 infection?

By  

Inpharma, Vol. 1, Iss. 1219, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (Atripla®): A Review of its Use in the Management of HIV Infection

By Deeks Emma D.   Perry Caroline M.  

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2315-2338

Adis International

Access to resources Recommend Favorite

Economic Analysis of Initial HIV Treatment: Efavirenz- versus Indinavir-Containing Triple Therapy

By Caro J.J.  

PharmacoEconomics, Vol. 19, Iss. 1, 2001-01 ,pp. : 95-104

Adis International

Access to resources Recommend Favorite

Efavirenz-based therapy a winner for HIV-1 infections

By  

Inpharma, Vol. 1, Iss. 1556, 2006-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Efavirenz + NRTIs most effective for HIV-1 infections

By  

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite